[A study of an immunosuppressive acidic protein (IAP) in patients with a bone tumor].
We evaluated an immunosuppressive acidic protein (IAP) as a tumor marker in cases of a tumor of the bone (benign, 21; primary malignant, 26; metastatic carcinoma, 12). The IAP positive rate of a primary malignant tumor of the bone was 60%, and the mean was 591 + 59.4 micrograms/ml. This rate of a benign tumor of the bone was 10%, and the mean was 382 +/- 31.3 micrograms/ml. IAP may represent a tumor marker in malignant tumors of the bone.
Mori
O
O
Dept. of Orthopedic Surgery, Kumamoto Univ. Med. School.
Yonemura
K
K
Morisawa
K
K
D014408:Biomarkers, Tumor / Q000032:analysis*; D001859:Bone Neoplasms / Q000032:analysis*; D002812:Chondroma / Q000032:analysis*; D002813:Chondrosarcoma / Q000032:analysis*; D006801:Humans; D009363:Neoplasm Proteins / Q000032:analysis*; D012516:Osteosarcoma / Q000032:analysis*
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; C030193:immunosuppressive acidic protein